Prognostic Nutritional Index (PNI) as a Potential Prognostic Tool for Exacerbation of COPD in Elderly Patients

Int J Chron Obstruct Pulmon Dis. 2023 Jun 7:18:1077-1090. doi: 10.2147/COPD.S385374. eCollection 2023.

Abstract

Purpose: In COPD, exacerbation of the disorder causes a deterioration in the quality-of-life and worsens respiratory dysfunction, leading to a poor prognosis. In recent years, nutritional indices have been reported as significant prognostic factors in various chronic diseases. However, the relationship between nutritional indicators and prognosis in elderly subjects with COPD has not been investigated.

Patients and methods: We enrolled 91 subjects who received COPD assessment tests (CAT), spirometry, blood tests, and multidetector computed tomography (MDCT). We divided the subjects into two groups according to age (<75 years (n=57) and ≥ 75 years (n=34)). The prognostic nutritional index (PNI) was used to assess immune-nutritional status and was calculated as 10 x serum albumin + 0.005 x total lymphocyte count. We then examined the relationship between PNI and clinical parameters, including exacerbation events.

Results: There was no significant correlation between the PNI and CAT, the FEV1%pred, or low attenuation volume percentage (LAV%). In the elderly group, there were significant differences between the groups with or without exacerbation in the CAT and PNI (p=0.008, p=0.004, respectively). FEV1%pred, neutrophil-to-lymphocyte ratio (NLR) and LAV% did not differ between the two groups. The analytical model combining CAT and PNI improved the prediction of exacerbations in the elderly subjects (p=0.0068).

Conclusion: In elderly subjects with COPD, CAT were associated significantly with the risk of COPD exacerbation, with PNI also a potential predictor. The combined assessment of CAT and PNI may be a useful prognostic tool in subjects with COPD.

Keywords: chronic obstructive pulmonary disease; exacerbation; prognostic nutritional index.

MeSH terms

  • Aged
  • Asthma*
  • Humans
  • Nutrition Assessment
  • Prednisone
  • Prognosis
  • Pulmonary Disease, Chronic Obstructive*

Substances

  • Prednisone

Supplementary concepts

  • Pulmonary Disease, Chronic Obstructive, Severe Early-Onset

Grants and funding

This research was partially supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (C) (19K12816 and 22K12836), and the Chiba Foundation for Health Promotion & Disease Prevention (No.1272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.